Further cautionary announcement Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Company”) Further cautionary announcement Shareholders are referred to the cautionary and cautionary renewal announcements published on SENS on 14 January 2019, 8 February 2019 and 8 March 2019, respectively, relating to an unsolicited offer received for the Remedica business unit (“Remedica”) in Cyprus. Ascendis Health is involved in ongoing negotiations regarding the potential disposal of Remedica and will update investors should a transaction be concluded. Shareholders are advised to continue to exercise caution when dealing in the Company’s securities until a further announcement is made. 24 April 2019 Bryanston Sponsor Questco Corporate Advisory Proprietary Limited Date: 24/04/2019 10:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.